Med-Design cannot pinpoint share price drop trigger?:
This article was originally published in Clinica
Executive Summary
Med-Design, which is currently negotiating licences for its retractable safety needle technology, says it is unaware of any fundamental reason for the recent decline in the price of its shares. The US company says it has had a positive response from potential licensees and that the sale of its shares appears to be due to "technical conditions associated with the liquidation of margin debt". Around one million needlestick accidents occur in the US each year, according to the American Hospital Association.